Amgen’s Cancer Drug Shows Big Promise

Amgen just dropped some major news: their new drug Imdelltra cut the risk of death by 40% for small cell lung cancer patients who didn’t respond to chemo. Plus, people lived over 5 months longer on average compared to standard treatment. Even symptoms like cough and shortness of breath improved! But here’s the twist—despite the breakthrough, retail investors aren’t exactly hyped yet. Would you bet on Amgen after this? #Amgen #CancerResearch #BiotechNews #Health